MCCP
CVS icon

Mission Creek Capital Partners’s CVS Health CVS Stock Holding History

Mission Creek Capital Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$225K Buy
5,958
+562
+10% +$43.3K 0.04% 208
2025
Q4 		$203K Buy
+5,396
New +$425K 0.04% 204
2025
Q1 		– Sell
-9,995
Closed -$323K – 204
2024
Q4 		$323K Buy
9,995
+2,324
+30% +$130K 0.07% 185
2024
Q3 		$482K Sell
7,671
-1,472
-16% -$85.9K 0.11% 156
2024
Q2 		$540K Sell
9,143
-10,125
-53% -$633K 0.14% 135
2024
Q1 		$1.54M Buy
19,268
+501
+3% +$38.3K 0.4% 70
2023
Q4 		$1.48M Sell
18,767
-1,110
-6% -$79K 0.38% 72
2023
Q3 		$1.39M Sell
19,877
-526
-3% -$37.3K 0.47% 68
2023
Q2 		$1.41M Sell
20,403
-1,392
-6% -$99K 0.45% 70
2023
Q1 		$1.62M Sell
21,795
-884
-4% -$74.1K 0.55% 63
2022
Q4 		$2.11M Sell
22,679
-389
-2% -$37.5K 0.76% 40
2022
Q3 		$2.2M Sell
23,068
-58
-0.3% -$5.74K 0.83% 34
2022
Q2 		$2.14M Sell
23,126
-137
-0.6% -$13.4K 0.72% 43
2022
Q1 		$2.35M Sell
23,263
-632
-3% -$66.4K 0.63% 46
2021
Q4 		$2.46M Sell
23,895
-54
-0.2% -$4.99K 0.49% 56
2021
Q3 		$2.03M Sell
23,949
-362
-1% -$30.3K 0.38% 63
2021
Q2 		$2.03M Sell
24,311
-384
-2% -$31.4K 0.33% 66
2021
Q1 		$1.86M Buy
24,695
+708
+3% +$51.6K 0.28% 67
2020
Q4 		$1.64M Sell
23,987
-1,921
-7% -$125K 0.5% 61
2020
Q3 		$1.51M Buy
25,908
+19,996
+338% +$1.24M 0.6% 49
2020
Q2 		$384K Buy
5,912
+10
+0.2% +$630 0.2% 118
2020
Q1 		$350K Sell
5,902
-400
-6% -$26.7K 0.19% 112
2019
Q4 		$468K Buy
+6,302
New +$442K 0.21% 117

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Mission Creek Capital Partners's CVS Position: Q1 2026 in Review

Mission Creek Capital Partners increased its CVS Health (CVS) stake by 10% in Q1 2026, buying an estimated $43.3K and bringing the position to 5,958 shares worth $225K. The position accounts for 0.04% of the portfolio, ranked #208.

Mission Creek Capital Partners first reported a position in CVS in Q4 2019 and has held it in 23 quarters since. The position peaked at $2.46M in Q4 2021. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Mission Creek Capital Partners held 5,958 shares of CVS Health worth $225K as of Q1 2026.
  • Mission Creek Capital Partners bought 562 CVS Health shares in Q1 2026, an estimated $43.3K.
  • CVS Health made up 0.04% of Mission Creek Capital Partners's portfolio in Q1 2026, its #208 holding.
  • Mission Creek Capital Partners first reported a position in CVS Health in Q4 2019 and has held it in 23 quarters since.
  • Mission Creek Capital Partners's CVS Health position peaked at $2.46M in Q4 2021.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Mission Creek Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.